Sentante’s debut at Houson Methodist’s
November 15, 2024
November 15, 2024
Sentante‘s debut at Houston Methodist’s advanced technology facility was an exciting moment! The inspiring feedback we’ve received about our system’s capabilities and ease of adoption highlights the potential to transform endovascular care.
Watch the video to see our system in action!
Our latest
news and publications
news and publications
-
Read
Sentante Introduces Digital Indeflator – InflanteJuly 07, 2026 -
Read
Sentante Receives CE Mark Approval unlocking commercialisation of its Endovascular Robotic platformMay 20, 2026 -
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026